News | December 15, 2022
LG Chem inks deal with Innovent Biologics for gout treatment candidate
LG Chem will receive totaling up to $95.5 million for the China rights
LG Chem will receive totaling up to $95.5 million for the China rights
The investment will enable the company to enter European markets as well as enhance margins in current markets
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Subscribe To Our Newsletter & Stay Updated
